Published in Gene Therapy Weekly, May 29th, 2003
According to recent research from Canada, "recent work has shown that plasmid DNA can be efficiently encapsulated in well-defined 'stabilized plasmid-lipid particles' (SPLP) that have potential as systemic gene therapy vehicles [Gene Ther, 1999;6:271]. In this work, we examine the influence of ligands that enhance cellular uptake on the transfection potency of SPLP."
"The ligand employed is a cationic poly(ethylene glycol) (PEG) lipid (CPL) consisting of a lipid anchor and a PEG(3400) spacer chain with four positive charges at the end of the PEG (CPL4),"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-05-29)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.